Begin main content

News and Events

Latest News

New at CADTH — December 2017

December 11, 2017
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Calls for Patient Input: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide

November 24, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Darunavir/cobicistat/emtricitabine/tenofovir a...

Calls for Patient Input: Dolutegravir and rilpivirine

November 23, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Dolutegravir and rilpivirine Brand name Generi...

Upcoming Events

2018 CADTH Symposium

April 15, 2018 - April 18, 2018
The CADTH Symposium is a must attend annual event for the Health Technology Assessment (HTA) community in Canada and beyond, and our 2018 event is no exception. It is an excellent opportunity to connect with Canadian and international experts to discuss what is being done — and what still needs to be done — to transform the way we manage health ...

HTAi 2018 Annual Meeting

June 1, 2018 - June 5, 2018
CADTH is pleased to be co-hosting the Health Technology Assessment international (HTAi) 2018 Annual Meeting in Vancouver, British Columbia, June 1 to 5, 2018. Dr. Tammy Clifford, Chief Scientist and Vice-President of Evidence Standards and Medical Devices at CADTH, is a co-chair of the International Scientific Programme Committee. The theme of t...